Sec. 602. Enhancing access to affordable medicines
111 words·~1 min read·
/bill/117/hr/7667/rh/section-602A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Section 505(j)(10)(A) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 355(j)(10)(A) ) is amended by striking clauses
(i)through
(iii)and inserting the following: a revision to the labeling of the listed drug has been approved by the Secretary within 90 days of when the application is otherwise eligible for approval under this subsection; the sponsor of the application agrees to submit revised labeling for the drug that is the subject of the application not later than 60 days after approval under this subsection of the application; the labeling revision described under clause
(i)does not include a change to the Warnings section of the labeling; and .
Connectionstraces to 1
Traces to 1 document
U.S. Code
Citation graph
cites case law
Sec. 602
Enhancing access to affordable medicines
Cites 1Cited by 0 across 0 sources